According to Aspen Pharmacare's latest financial reports the company's current revenue (TTM) is $2.38 B. In 2022 the company made a revenue of $2.38 B a decrease over the years 2021 revenue that were of $2.63 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 | $2.38 B | -9.55% |
2021 | $2.63 B | 17.32% |
2020 | $2.24 B | -18.76% |
2019 | $2.76 B | -11.09% |
2018 | $3.10 B | -2.06% |
2017 | $3.17 B | 31.64% |
2016 | $2.41 B | -18.27% |
2015 | $2.94 B | 5.79% |
2014 | $2.78 B | 42.76% |
2013 | $1.95 B | 4.29% |
2012 | $1.87 B | 2.48% |
2011 | $1.82 B | 38.06% |
2010 | $1.32 B | 20.85% |
2009 | $1.09 B | 75.64% |
2008 | $0.62 B | 7.61% |
2007 | $0.57 B | 19.48% |
2006 | $0.48 B | 12.43% |
2005 | $0.43 B | 19.93% |
2004 | $0.35 B | 19.99% |
2003 | $0.29 B |